Stockscreener 앱 받기
0.4199
4.46%
-0.0196
시간 외 거래:
.42
0.000100
+0.02%
전일 마감가:
$0.4395
열려 있는:
$0.458
하루 거래량:
2.09M
Relative Volume:
0.07
시가총액:
$25.22M
수익:
-
순이익/손실:
$-16.26M
주가수익비율:
-0.3554
EPS:
-1.1814
순현금흐름:
$-13.50M
1주 성능:
-23.65%
1개월 성능:
+1.47%
6개월 성능:
+46.87%
1년 성능:
-79.01%
1일 변동 폭
$0.4172
$0.4629
1주일 범위
$0.4011
$0.60
52주 변동 폭
$0.1853
$3.1663
인텐시티 테라퓨틱스 Stock (INTS) Company Profile
명칭
Intensity Therapeutics Inc
전화
203-221-7381
주소
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
INTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.4199 | 26.40M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
인텐시티 테라퓨틱스 주식(INTS)의 최신 뉴스
MSN Money - MSN
Intensity Therapeutics to present two posters ay SABCS - MSN
Immuron (IMRN) struggles after announcing trial results - MSN
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - Yahoo Finance
Value Recap: Is Intensity Therapeutics Inc stock positioned for digital transformationJuly 2025 Snapshot & Technical Confirmation Trade Alerts - moha.gov.vn
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium - PR Newswire
What drives Intensity Therapeutics Inc stock priceTechnology Stock Trends & Explosive Profit Potential - earlytimes.in
Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year - MSN
You might want to take a look at Intensity Therapeutics Inc (INTS) now - setenews.com
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - marketscreener.com
HC Wainwright & Co. initiates coverage of Pasithea Therapeutics (KTTA) with buy recommendation - MSN
Intensity Therapeutics granted 180-day extension to regain Nasdaq compliance - MSN
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Update Report: How Intensity Therapeutics Inc stock benefits from global expansionPortfolio Gains Summary & AI Based Trade Execution Alerts - moha.gov.vn
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule - Investing.com Nigeria
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance - MSN
Intensity Therapeutics stock rises after securing Nasdaq listing extension By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock rises after securing Nasdaq listing extension - Investing.com
Intensity Therapeutics Gets Extension to Regain Nasdaq Minimum Price Requirement - marketscreener.com
Intensity Therapeutics Granted Nasdaq Compliance Extension - TipRanks
Intensity Therapeutics granted 180-day extension - marketscreener.com
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule By Investing.com - Investing.com South Africa
Intensity Therapeutics jumps after Nasdaq grants compliance extension - TradingView — Track All Markets
Intensity Therapeutics, Inc. (INTS) 18.98% in Intraday Trading: Surge Ahead of Conference Presentations - Stocks Telegraph
Intensity Therapeutics expands at-the-market offering - MSN
Intensity Therapeutics files for offering of up to $30 million common stockSEC filing - marketscreener.com
Intensity Therapeutics expands at-the-market offering program to $30 million - Investing.com Australia
Intensity Therapeutics announces two presentations at the upcoming 2025 San Antonio Breast Cancer Symposium - marketscreener.com
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium - Nasdaq
Intensity Therapeutics expands at-the-market offering program to $30 million By Investing.com - Investing.com South Africa
Intensity Therapeutics Expands At-The-Market Offering - TipRanks
Intensity Therapeutics Expands ATM Offering to $30 Million - TradingView — Track All Markets
Chipmakers Recap: Why FARO Technologies Inc. stock could see breakout soonWall Street Watch & Momentum Based Trading Signals - BỘ NỘI VỤ
How Intensity Therapeutics Inc. stock benefits from global expansionEarnings Recap Report & Verified Chart Pattern Signals - Newser
Delving into the physics of cancer, with Lew Bender - pharmaphorum
Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga
The time has not yet come to remove your chips from the table: Intensity Therapeutics Inc (INTS) - setenews.com
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
What analysts say about Intensity Therapeutics Inc stockSwing Trading Watchlist & Free Turn Volatility To Profit - earlytimes.in
Can Intensity Therapeutics Inc. stock resist sector downturnsJuly 2025 Rallies & Weekly High Momentum Picks - moha.gov.vn
Why Intensity Therapeutics Inc. stock appeals to analystsQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire) - Aktiellt
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - Aktiellt
Trading Recap: Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - BỘ NỘI VỤ
Intensity Therapeutics Inc (INTS) looking to reclaim success with recent performance - setenews.com
How Intensity Therapeutics Inc. stock reacts to oil prices2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Will Intensity Therapeutics Inc. stock benefit from AI adoptionMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis tools2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Will a bounce in Intensity Therapeutics Inc. offer an exitQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Will Intensity Therapeutics Inc. stock reach all time highs in 2025July 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
인텐시티 테라퓨틱스 (INTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):